| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/28/2004 | EP1411967A2 Blocking peptide for inflammatory cell secretion |
| 04/28/2004 | EP1411966A2 Method for treating secondary tissue degeneration associated with central nervous system injury |
| 04/28/2004 | EP1411965A1 Methods and compositions for controlling protein assembly or aggregation |
| 04/28/2004 | EP1411960A1 Fortified rice bran food product and method for promoting cardiovascular health |
| 04/28/2004 | EP1411955A1 Sucralose formulations to mask unpleasant tastes |
| 04/28/2004 | EP1411946A1 Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses |
| 04/28/2004 | EP1411943A2 Methods for treatment of cognitive and menopausal disorders with d-threo methylphenidate |
| 04/28/2004 | EP1411940A1 Bridged piperidine derivatives as melanocortin receptor agonists |
| 04/28/2004 | EP1411939A2 Gaba a-receptor-modulators having nmda-antagonistic activity |
| 04/28/2004 | EP1411932A1 Substituted oxazolidinones for combinational therapy |
| 04/28/2004 | EP1411931A1 Zonisamide use in headache |
| 04/28/2004 | EP1411928A1 Viral polymerase inhibitors |
| 04/28/2004 | EP1411926A1 Integrin inhibitors for the treatment of eye diseases |
| 04/28/2004 | EP1411924A1 Hypertension treatment |
| 04/28/2004 | EP1411922A1 Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins |
| 04/28/2004 | EP1411918A2 Methods to mobilize progenitor/stem cells |
| 04/28/2004 | EP1411914A2 Use of a pde4 inhibitor in combination with an anticholinergic agent for the treatment of pulmonary disease such as asthma |
| 04/28/2004 | EP1411913A1 Antimicrobial nanoemulsion compositions and methods |
| 04/28/2004 | EP1411911A1 Beta-adrenergic blockade reversal of catabolism after severe burn |
| 04/28/2004 | EP1411910A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 04/28/2004 | EP1411907A1 Inhibitors of hb-egf (erbb) receptors for treating myeloma |
| 04/28/2004 | EP1411905A1 Sustained release delivery system |
| 04/28/2004 | EP1411904A1 Sustained release pharmaceutical composition |
| 04/28/2004 | EP1411900A2 PHARMACEUTICAL COMPOSITIONS FOR THE COORDINATED DELIVERY OF NSAIDs |
| 04/28/2004 | EP1411899A2 Taste masking composition |
| 04/28/2004 | EP1411894A2 Pharmaceutical preparations containing ion exchange resins charged with active ingredients |
| 04/28/2004 | EP1411889A1 Cream for treatment of skin injured by the sun |
| 04/28/2004 | EP1411861A2 Biodegradable injectable implants and related methods of manufacture and use |
| 04/28/2004 | EP1411817A2 Method and apparatus for the photomodulation of living cells |
| 04/28/2004 | EP1307539A4 Gene expression profile for kshv infection and methods for treating same |
| 04/28/2004 | EP1294682B1 Acylphenyl urea derivatives, methods for the production thereof and use thereof as a medicament |
| 04/28/2004 | EP1286684B1 use of cxcr4 antagonists for treating autoimmune diseases and cancer |
| 04/28/2004 | EP1263718B1 Novel use of phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1263714B1 Novel phenylheteroalkylamine derivatives |
| 04/28/2004 | EP1259190B1 Method for making, loading and sealing a cell or drug encapsulation device, and such a device |
| 04/28/2004 | EP1255559B1 Use of inhibitors of caspase-3 or caspase-activated desoxyribonuclease (cad) for treating cardiac disease |
| 04/28/2004 | EP1162981B1 Dexrazoxane for the treatment of accidental extravasation of anthracyclines |
| 04/28/2004 | EP1058555B1 Costimulatory blockade and mixed chimerism in allotransplantation |
| 04/28/2004 | EP0912174B1 Alteration of circadian rhythmicity with non-peptidal neurikinin-1 receptor antagonists |
| 04/28/2004 | EP0910645B1 A KINASE CAPABLE OF SITE-SPECIFIC PHOSPHORYLATION OF I-kappa-B-alpha |
| 04/28/2004 | EP0626861B2 Treatment for asthma |
| 04/28/2004 | CN1492875A TTK in diagnosis and as a therapeutic target in cancer |
| 04/28/2004 | CN1492868A Quinuclidine carbamate derivatives and their use as m3 antigonists |
| 04/28/2004 | CN1492852A N-phenpropylcyclopentyl-substituted glutaramide derivatives as NEP inhibitors for FSAD |
| 04/28/2004 | CN1492767A Modified anti-EGFR antibody with reduced immunogenicity |
| 04/28/2004 | CN1492766A Prevention of diabetes by administration of GnRH antagonists |
| 04/28/2004 | CN1492761A Injectable pharmaceutical composition for treatment and reversal of erectile dysfunction |
| 04/28/2004 | CN1492759A Device and method for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 04/28/2004 | CN1492757A Use of accelerated lymphocyte homing agents for manufacture of medicament for treating delayed graft function in tissue transplant |
| 04/28/2004 | CN1492735A Non invasive measurements of chemical substances |
| 04/28/2004 | CN1147505C G-protein receptor HTNAD 29 |
| 04/28/2004 | CN1147317C Combination of tyrosine kinase inhibitor and chemical castration and its use in pharmaceutical production |
| 04/28/2004 | CN1147300C Vitronectin receptor antagonist |
| 04/28/2004 | CA2447199A1 Homing of embryonic stem cells to a target zone in tissue using active therapeutics or substances |
| 04/27/2004 | US6727353 Nucleic acid encoding Kv10.1, a voltage-gated potassium channel from human brain |
| 04/27/2004 | US6727254 8-(bis-(phenyl) methyl)-3-heteroaryl-8-azabicyclo-(3.2.1)octan-3-ols and derivatives, useful in treating pain, anxiety, cough, asthma, depresion and alcohol abuse |
| 04/27/2004 | US6727253 Use of a topo ii catalytic nhibitor such as the bisdioxopiperazine icrf-187, a quinoline, aclarubicin, and an acridine. |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727242 Pharmacological treatment for sleep apnea |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6727225 TWEAK receptor |
| 04/27/2004 | US6727075 Measuring lipid peroxidation in mammals; obtain tissue or fluid sample evaluate the concentration of prostaglandin isomer marker present, compare to control, amplified concentration of the marker indicates oxidative stress |
| 04/27/2004 | US6726927 Comprises core granulation formed by dry mixing drug or its salt with alkaline substance and pharmaceutical excipients which can be quantitatively filled into an empty hard gelatin capsule; provides gastrointestinal cytoprotective benefit |
| 04/27/2004 | US6726925 Bi-layer membrane comprising phospholipid and lysolipid; drug delivery, medical diagnosis |
| 04/27/2004 | US6726924 Oral liposomal delivery system |
| 04/27/2004 | US6726923 Prosthetic device placed on the outside surface of the vessel or graft which then elutes antiproliferatives from a matrix |
| 04/27/2004 | US6726908 Comprising amoxycillin and potassium clavulanate in a ratio of 10:1 to 20:1 and used in the emperic treatment of infections potentially caused by drug-resistant streptoccocus pneumoniae; respiratory system disorders |
| 04/27/2004 | US6726906 Orally administered poly(n,n-di(2,3-dihydroxypropyl) allylamine)hydrochloride and tetrahydrolipstatin lipase inhibitor; hypertriglyceridemia; side effect reduction |
| 04/27/2004 | US6726895 Tumor radiotherapy |
| 04/27/2004 | US6726860 Production scale method of forming microparticles |
| 04/27/2004 | CA2317530C Dysuria remedies |
| 04/27/2004 | CA2299400C Method for treating disease-related or drug-induced dyskinesias |
| 04/27/2004 | CA2271750C Prolonged anesthesia in joints and body spaces |
| 04/22/2004 | WO2004033484A2 Use of stable glutamine derivatives to improve drug absorption |
| 04/22/2004 | WO2004032979A2 Acidified chlorite compositions containing nitrogenous stabilizers and systems and methods related thereto |
| 04/22/2004 | WO2004032969A1 Modulation of immune function |
| 04/22/2004 | WO2004032968A1 Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity |
| 04/22/2004 | WO2004032967A1 Association between a ppar ligand and an antioxidant agent and use thereof for treating obesity |
| 04/22/2004 | WO2004032964A1 Remedies for allergic diseases |
| 04/22/2004 | WO2004032963A2 Photokinetic delivery of biologically active substances using pulsed incoherent light |
| 04/22/2004 | WO2004032950A1 Method and composition for reducing cravings for a craved substance |
| 04/22/2004 | WO2004032943A1 Combination preparation of hyaluronic acid and at least one local anesthetic and the use thereof |
| 04/22/2004 | WO2004032935A1 Treatment of aml |
| 04/22/2004 | WO2004032925A1 Use of imatinib (glivec, sti-571) to inhibit breast cancer resistance protein (bcrp)-mediated resistance to therapeutic agents |
| 04/22/2004 | WO2004032923A1 Epothilone derivatives for the treatment of multiple myeloma |
| 04/22/2004 | WO2004032922A1 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist |
| 04/22/2004 | WO2004032917A1 Composition for preventing/treating the expression of clinical symptom in disease caused by mitochondrial dysfunction |
| 04/22/2004 | WO2004032881A2 Implantation of encapsulated biological materials for treating diseases |
| 04/22/2004 | WO2004032876A2 Deguelin as a chemopreventive agent for lung cancer |
| 04/22/2004 | WO2004032874A2 AZAINDOLE DERIVATIVES AS INHIBITORS OF p38 KINASE |
| 04/22/2004 | WO2004032873A2 Therapeutic combination of carnitine and antioxidant polyphenols |
| 04/22/2004 | WO2004032872A2 Epo D + 5-FU/GEMCITABINE |
| 04/22/2004 | WO2004032869A2 Identification of anti-hiv compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid |
| 04/22/2004 | WO2004032867A2 Molecules preferentially associated with effector t cells or regulatory t cells and methods of their use |
| 04/22/2004 | WO2004032863A2 Oral formulations for proteins and polypeptides |
| 04/22/2004 | WO2004032849A2 Methods of administering fgf18 |
| 04/22/2004 | WO2004032844A2 Compositions and methods for treating pain |
| 04/22/2004 | WO2004032829A2 Immunostimulatory compositions and methods of stimulating an immune response |
| 04/22/2004 | WO2004032826A2 Process for preparing tannate tablet capsule or other solid dosage forms |
| 04/22/2004 | WO2004032629A1 Mixed compositions for controlling parasitic insects |